Skip to content

Clinical trials

Observational Heredodegenerative Disorders, Nervous System trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heredodegenerative Disorders, Nervous System Phase: Observational Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20091
20121
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
State University of New York at Buffalo2
Alnylam Pharmaceuticals1
National Human Genome Research Institute (NHGRI)1
SwanBio Therapeutics, Inc.1
University of Exeter1
University of South Florida1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heredodegenerative Disorders, Nervous System8
Genetic Diseases, Inborn2
Metabolic Diseases2
Metabolism, Inborn Errors2
Mitochondrial Diseases2
Nerve Degeneration2
Nervous System Diseases2
Neurodegenerative Diseases2
Optic Atrophy2
Parkinson Disease2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.